- HEOR (Health Economics and Outcomes Research) services are crucial in evaluating the cost-effectiveness, value, and impact of healthcare interventions, providing essential insights for healthcare decision-making, reimbursement strategies, and policy formulation. These services play a key role in assessing treatment outcomes, improving healthcare delivery, and optimizing resource allocation
- The demand for HEOR services is primarily driven by the increasing need for cost-effective healthcare solutions, the shift towards value-based healthcare, and the rising focus on improving patient outcomes while controlling healthcare costs. Healthcare providers, payers, and governments rely on HEOR to make informed decisions about treatment options, healthcare policies, and reimbursement models
- North America is a dominant market for HEOR services, driven by a well-established healthcare infrastructure, substantial investments in research and development, and the widespread use of data analytics and real-world evidence to guide healthcare decisions. The U.S., in particular, leads the global HEOR market by integrating health economics into clinical and policy decision-making
- For instance, the U.S. healthcare system uses HEOR data extensively to evaluate the economic impact of new treatments, pharmaceuticals, and medical devices, influencing reimbursement and policy decisions at both state and federal levels
- Globally, HEOR services are critical for guiding health technology assessments (HTA), shaping healthcare policies, and supporting the introduction of new treatments by demonstrating their cost-effectiveness and long-term value in improving patient outcomes
